인쇄하기
취소

The Samsung’s biopharmaceutical business is about to face KRW 1 trillion sales

Published: 2015-09-08 15:27:50
Updated: 2015-09-08 15:27:50

The Samsung’s biopharmaceutical business, a new growth power of the company, is expected to enter a period of active growth.

The key of its biopharmaceutical business is classified into Samsung Biologics(manufacturing and distribution) and Samsung Bioepis(R&D).

Located in Songdo, the 1st factory having a 30 thousand liter scale has begun to produce CMOs since July 2013.

Its rate of CMO opera...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.